Exploring the druggability of the binding site of aurovertin, an exogenous allosteric inhibitor of FOF1-ATP synthase

Overview of attention for article published in Frontiers in Pharmacology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 257 followers.

You can read the whole story in this article: https://t.co/tlM0sJP095

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.